Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atovaquone for COVID-19
NCT04456153Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atovaquone in coronavirus disease 2019 (COVID-19), sponsored by UT Southwestern Medical Center. Started Jul 2020; status: completed.
02
Drugs
atovaquone
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04456153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04456153.